✦ LIBER ✦

Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes

✍ Scribed by Herman, Gary A.; Bergman, Arthur; Yi, Bingming; Kipnes, Mark

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term safety, tolerability, and effi

✍ Masato Odawara; Takashi Kadowaki; Naoko Tajima; Mikio Nishii; Tadaaki Taniguchi; 📂 Article 📅 2011 🏛 Springer Japan 🌐 English ⚖ 377 KB

Efficacy and tolerability of the dipepti

✍ R. Scott; M. Wu; M. Sanchez; P. Stein 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 546 KB

Efficacy and Safety of the Dipeptidyl Pe

✍ Charbonnel, B.; Karasik, A.; Liu, J.; Wu, M.; Meininger, G. 📂 Article 📅 2006 🏛 American Diabetes Association 🌐 English ⚖ 148 KB

EFFECT OF THE DIPEPTIDYL PEPTIDASE-4 INH

✍ Sara Stafford; Dariush Elahi; Graydon S. Meneilly 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Efficacy and safety of the dipeptidyl pe

✍ I. Raz; M. Hanefeld; L. Xu; C. Caria; D. Williams-Herman; H. Khatami; Sitaglipti 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 160 KB

Efficacy and safety of the dipeptidyl pe

✍ Rhee, E. J.; Lee, W. Y.; Min, K. W.; Shivane, V. K.; Sosale, A. R.; Jang, H. C.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 509 KB